The weekly litigation news digest is live. Subscribe now

Detection And Treatment Of Disease Exhibiting Disease Cell Heterogeneity And Systems And Methods For Communicating Test Results - EP4123032

The patent EP4123032 was granted to Guardant Health on Feb 5, 2025. The application was originally filed on Dec 28, 2015 under application number EP22176398A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4123032

GUARDANT HEALTH
Application Number
EP22176398A
Filing Date
Dec 28, 2015
Status
Granted And Under Opposition
Jan 3, 2025
Publication Date
Feb 5, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SOPHIA GENETICSNov 5, 2025IKADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2014US72383
DESCRIPTIONUS2014227705
DESCRIPTIONWO2013142389
DESCRIPTIONWO2014149134
EXAMINATIONWO2014043763
OPPOSITIONWO2014043763
OPPOSITIONWO2014165549
OPPOSITIONWO2014191938
SEARCHWO2014165549

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents